Literature DB >> 7286055

Serum theophylline levels after use of an anhydrous crystalline theophylline suppository.

J Aarbakke, A Høylandskjaer, O N Gamst.   

Abstract

The absorption of theophylline from a suppository not containing ethylenediamine was tested in 9 healthy volunteers. AUC after rectal administration of anhydrous crystalline theophylline 250 mg (AUCrectal) was compared with the AUC after oral administration of microcrystalline theophylline 250 mg (Nuelin; AUCoral) in a randomized, cross-over study. The ratio AUCrectal/AUCoral was 0.75 at 10h, and the ratio AUCrectal x beta rectal/AUCoral x beta oral extrapolated to infinite time was 0.83. A mean concentration of 5.7 micrograms/ml was reached 3.7 h after a single rectal dose. The absorption studied were performed with suppositories stored for 15 weeks at 22 degrees C. No effect on the in vitro release rate of theophylline from the suppository was observed during storage at room temperature from 3 to 31 weeks after production. Since aminophylline suppositories are known to decompose upon storage, the results suggest that a formulation without ethylenediamine is preferable for the rectal administration of theophylline.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7286055     DOI: 10.1007/BF00542098

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  15 in total

1.  The resorption of theophyllamine (theophylline ethylendiamine); blood concentrations after intravenous, peroral, rectal intramuscular administration.

Authors:  E K BRODWALL
Journal:  Acta Med Scand       Date:  1953

2.  Biopharmaceutics of aminophylline suppositories. II. In vitro release rate during storage.

Authors:  C J de Blaey; J J Rutten-Kingma
Journal:  Pharm Acta Helv       Date:  1977

3.  Rational intravenous doses of theophylline.

Authors:  P A Mitenko; R I Ogilvie
Journal:  N Engl J Med       Date:  1973-09-20       Impact factor: 91.245

4.  Pharmacologic effects of intravenously administered aminophylline in asthmatic children.

Authors:  R Maselli; G L Casal; E F Ellis
Journal:  J Pediatr       Date:  1970-05       Impact factor: 4.406

5.  Evaluation of the absorption from 15 commercial theophylline products indicating deficiencies in currently applied bioavailability criteria.

Authors:  R A Upton; L Sansom; T W Guentert; J R Powell; J F Thiercelin; V P Shah; P E Coates; S Riegelman
Journal:  J Pharmacokinet Biopharm       Date:  1980-06

6.  Decomposition of aminophylline in suppository formulations.

Authors:  J F Brower; E C Juenge; D P Page; M L Dow
Journal:  J Pharm Sci       Date:  1980-08       Impact factor: 3.534

7.  Plasma theophylline level and effect on lung function after oral and rectal administration of aminophylline.

Authors:  H Lamont; E Moerman; M Bogaert; M Van Der Straeten; R Pauwels
Journal:  Eur J Clin Pharmacol       Date:  1979-07       Impact factor: 2.953

8.  Bioavailability and pharmacokinetics in man of orally administered theophylline.

Authors:  F Nielsen-Kudsk; I Magnussen; T S Jensen; K Naeser
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1980-03

9.  Administration of aminophylline (theophylline ethylenediamine).

Authors:  S H WAXLER; J A SCHACK
Journal:  J Am Med Assoc       Date:  1950-06-24

10.  Disposition and clinical pharmacokinetics of microcrystalline theophylline.

Authors:  J H Jonkman; W C Berg; R Schoenmaker; R A de Zeeuw; J E Greving; N G Orie
Journal:  Eur J Clin Pharmacol       Date:  1980-05       Impact factor: 2.953

View more
  1 in total

Review 1.  Influence of endogenous and exogenous effectors on the pharmacokinetics of theophylline. Focus on biotransformation.

Authors:  U Tröger; F P Meyer
Journal:  Clin Pharmacokinet       Date:  1995-04       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.